Top Markets
#1 MarsCoin MarsCoin +46.78%
#2 Palladium Network Palladium Network +27.95%
#3 Siren Siren +27.34%
#4 Status Status +24.27%
#5 Useless Coin Useless Coin +19.40%
#6 BankrCoin BankrCoin +15.62%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.16%
#8 Arweave Arweave +13.54%
#9 Ankr Network Ankr Network +13.48%
#10 Bedrock Bedrock +13.11%
Coin of the day
MarsCoin MarsCoin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited

TaiGen Biopharmaceuticals Holdings Limited

4157
Rang in Aktien #18445
TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm... TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm dedicated to pioneering innovative treatments for life-altering diseases. Its robust development pipeline features several key assets. Among these is Taigexyn (Nemonoxacin), a non-fluorinated quinolone antibiotic currently being advanced for the treatment of various bacterial infections, including community-acquired pneumonia and diabetic foot infections. The company is also progressing Burixafor, a stem cell mobilizer with applications in stem cell transplantation and chemosensitization. Further contributing to its portfolio is TG-1000, an antiviral medication designed to combat influenza A, B, and the avian influenza H7N9 strain. Additionally, Furaprevir, a hepatitis C virus (HCV) protease inhibitor, is under development for managing chronic hepatitis C. Established in 2001, TaiGen Biopharmaceuticals maintains its headquarters in Taipei City, Taiwan.
Aktienkurs
$0.27824149
Marktkapitalisierung
$198.06M
Veränderung (1 Tag)
-1.24%
Veränderung (1 Jahr)
-11.01%
Land
TW
Handel TaiGen Biopharmaceuticals Holdings Limited (4157)

Kategorie

Healthcare
Dividendenhistorie für TaiGen Biopharmaceuticals Holdings Limited (4157)
TaiGen Biopharmaceuticals Holdings Limited (Aktienkürzel: 4157) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für TaiGen Biopharmaceuticals Holdings Limited (4157) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Dividendenzahlungen Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH